AI tool MetaVision3D creates detailed 3D maps of mouse brain metabolism, offering new insights into Alzheimer's and other ...

Mitochondria are the powerhouses in our cells, producing the energy for all vital processes. Using cryo-electron tomography, ...

It is a detailed view of the brain like never seen before.

Norwegian startup Visoid has raised fresh funds for its AI software, which helps architects turn 3D models into striking ...

Shares of 2seventy bio, Inc. TSVT gained 5.26% after the company announced a definitive merger agreement with Bristol Myers ...

The agreement was signed in a letter of intent March 3 to set the groundwork for whether government health programs in different provinces and territories will cover the drug's cost for patients, ...

It has been about a month since the last earnings report for Regeneron (REGN). Shares have lost about 4.1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...

In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other worst performing large cap stocks to buy according to analysts. On January ...

Meshy is a 3D generative AI toolbox designed to streamline the creation of 3D assets from text or images, significantly accelerating the 3D workflow for designers, artists, and developers. By ...

Drucker honored District 16’s seven Regeneron Science Talent Search semifinalists and finalists. The Regeneron Science Talent Search scholars were selected from nearly 2,500 entrants from 795 ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

On Thursday, Evercore ISI adjusted its price target for Regeneron (NASDAQ:REGN) Pharmaceuticals (NASDAQ: REGN), bringing it down slightly to $1,170 from the previous $1,175, while ...